Review

Therapeutic approaches to language skills in major neurodegenerative disorders: a literature review

Volume: 11 Number: 1 January 4, 2025
EN

Therapeutic approaches to language skills in major neurodegenerative disorders: a literature review

Abstract

Major Neurodegenerative Disorders (MNDs) impact a large number of individuals globally. Individuals with neurodegenerative diseases have a significant problem due to the gradual development of communication difficulties. This is a review article to address the latest ways to manage and help individuals with language problems because of neurological diseases like Alzheimer's disease, mild cognitive impairment (MCI), and primary progressive aphasia (PPA). In the beginning we'll discuss the diseases, and then we'll be discussing how to treat them. The therapies used for Alzheimer's disease and PPA have been subject to extensive research. Therefore, the techniques follow a more structured way. However, there is a limited number of research in MCI and the strategies used in MCI mostly concentrate on enhancing the communication abilities of patients and their caregivers. There is a need for more research to increase approaches for speech and language therapy, as there is limited research on intervention in Turkish patients with MCI, PPA and Alzheimer's disease. It is critical to have evidence-based practice in MNDs, and more research is required to understand the effectiveness of speech and language therapy.

Keywords

References

  1. 1. Dugger BN, Dickson DW. Pathology of Neurodegenerative Diseases. Cold Spring Harb Perspect Biol. 2017;9(7):a028035. doi: 10.1101/cshperspect.a028035.
  2. 2. Mesulam MM. Primary progressive aphasia. Ann Neurol. 2001;49(4):425-32. doi: 10.1002/ana.91.
  3. 3. Boschi V, Catricalà E, Consonni M, Chesi C, Moro A, Cappa SF. Connected Speech in Neurodegenerative Language Disorders: A Review. Front Psychol. 2017;8:269. doi: 10.3389/fpsyg.2017.00269.
  4. 4. Gauthier S, Reisberg B, Zaudig M, et al; International Psychogeriatric Association Expert Conference on mild cognitive impairment. Mild cognitive impairment. Lancet. 2006;367(9518):1262-1270. doi: 10.1016/S0140-6736(06)68542-5.
  5. 5. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-308. doi: 10.1001/archneur.56.3.303.
  6. 6. Taler V, Phillips NA. Language performance in Alzheimer's disease and mild cognitive impairment: a comparative review. J Clin Exp Neuropsychol. 2008;30(5):501-556. doi: 10.1080/13803390701550128.
  7. 7. McCullough KC, Bayles KA, Bouldin ED. Language Performance of Individuals at Risk for Mild Cognitive Impairment. J Speech Lang Hear Res. 2019;62(3):706-722. doi: 10.1044/2018_JSLHR-L-18-0232.
  8. 8. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270-279. doi: 10.1016/j.jalz.2011.03.008.

Details

Primary Language

English

Subjects

Neurology and Neuromuscular Diseases , Rehabilitation

Journal Section

Review

Early Pub Date

July 27, 2024

Publication Date

January 4, 2025

Submission Date

April 16, 2024

Acceptance Date

July 17, 2024

Published in Issue

Year 2025 Volume: 11 Number: 1

AMA
1.Karalı FS, Tosun S, Çınar N. Therapeutic approaches to language skills in major neurodegenerative disorders: a literature review. Eur Res J. 2025;11(1):123-128. doi:10.18621/eurj.1467080